AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2025)
AVITA Medical (RCEL) posted Total Non-Current Liabilities of $71.8 million for Q4 2025, up 4.76% on a QoQ basis from $68.5 million in Q3 2025, and little changed year-over-year from $72.0 million in Q4 2024.
AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
AVITA Medical's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $71.8 million for Q4 2025.
- Quarterly Total Non-Current Liabilities changed 0.23% year-over-year to $71.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $71.8 million (changed 0.23% YoY) and the FY2025 annual result came in at $71.8 million, changed 0.23% from the prior year.
- Total Non-Current Liabilities was $71.8 million for Q4 2025 at AVITA Medical, up from $68.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $72.0 million in Q4 2024 and bottomed at $8.1 million in Q1 2022.
- A 5-year average of $41.6 million and a median of $59.3 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities fell 11.18% — and 2023, when it jumped 405.49%.
- AVITA Medical's Total Non-Current Liabilities stood at $11.3 million in 2021, then gained by 3.02% to $11.6 million in 2022, then soared by 405.49% to $58.7 million in 2023, then increased by 22.53% to $72.0 million in 2024, then slipped by 0.23% to $71.8 million in 2025.
- Business Quant data shows RCEL's Total Non-Current Liabilities at $71.8 million in Q4 2025, $68.5 million in Q3 2025, and $69.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 71.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.80 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Jun 30, 2025 | 69.08 Mn |
| Mar 31, 2025 | 71.01 Mn |
| Dec 31, 2024 | 71.97 Mn |
| Sep 30, 2024 | 65.84 Mn |
| Jun 30, 2024 | 61.55 Mn |
| Mar 31, 2024 | 59.96 Mn |
| Dec 31, 2023 | 58.73 Mn |
| Dec 31, 2022 | 11.62 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | 9.18 Mn |
| Jun 30, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.13 Mn |
| Jun 30, 2020 | 10.06 Mn |
| Jun 30, 2019 | 465,625.64 |
| Jun 30, 2018 | 101,698.83 |